Neonatal Drug ADR Association Dataset

Published: 19 November 2024| Version 1 | DOI: 10.17632/ppd2c7sz8j.1
Contributors:
Ronalda M,

Description

The Neonatal Drug ADR Association Dataset, extracted from the FDA Adverse Event Reporting System (FAERS), focuses on 140 neonatal health conditions. It comprises 32,441 unique instances, each documenting a drug, its associated adverse drug reaction (ADR), and metadata such as the drug's outcome, patient gender, age, and weight. While gender, age, and weight data are included, these attributes are missing for some instances due to unreported information from patients or medical practitioners. This comprehensive dataset, free of duplicates, offers valuable insights into neonatal pharmacovigilance, aiding research in drug safety, ADR patterns, and treatment outcomes for this vulnerable population.

Files

Steps to reproduce

The dataset was manually curated using publicly available data from the FDA Adverse Event Reporting System (FAERS), focusing on neonatal cases involving adverse drug reactions (ADRs) reporting data. Duplicates were identified and removed to ensure the dataset contained unique instances. Data with incomplete or unreported fields (e.g., missing gender, age, or weight) was retained to reflect real-world reporting challenges. This dataset may require pre-processing depending on the task.

Institutions

National Institute of Technology Srinagar

Categories

Drug Adverse Reactions, Pharmacovigilance, Neonatal Health, Neonatal Physiology, Predictive Modeling

Licence